M

Mankind Pharma Ltd
NSE:MANKIND

Watchlist Manager
Mankind Pharma Ltd
NSE:MANKIND
Watchlist
Price: 2 998.4 INR 6.89% Market Closed
Market Cap: 1.2T INR
Have any thoughts about
Mankind Pharma Ltd?
Write Note

Wall Street
Price Targets

MANKIND Price Targets Summary
Mankind Pharma Ltd

Wall Street analysts forecast MANKIND stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 828.17 INR with a low forecast of 2 060.4 INR and a high forecast of 3 465 INR.

Lowest
Price Target
2 060.4 INR
31% Downside
Average
Price Target
2 828.17 INR
6% Downside
Highest
Price Target
3 465 INR
16% Upside
Mankind Pharma Ltd Competitors:
Price Targets
200670
Humedix Co Ltd
14% Upside
PFIZER
Pfizer Ltd
33% Upside
SAN
Sanofi SA
25% Upside
POLB
Poolbeg Pharma PLC
228% Upside
ORCHPHARMA
Orchid Pharma Ltd
5% Downside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
17% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
36% Upside

Revenue
Forecast

Revenue Estimate
Mankind Pharma Ltd

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is 20%.

18%
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mankind Pharma Ltd

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's operating income is 11%. The projected CAGR for the next 3 years is 24%.

11%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Mankind Pharma Ltd

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's net income is 15%. The projected CAGR for the next 3 years is 18%.

15%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MANKIND's stock price target?
Price Target
2 828.17 INR

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 828.17 INR with a low forecast of 2 060.4 INR and a high forecast of 3 465 INR.

What is Mankind Pharma Ltd's Revenue forecast?
Projected CAGR
20%

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is 20%.

What is Mankind Pharma Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's operating income is 11%. The projected CAGR for the next 3 years is 24%.

What is Mankind Pharma Ltd's Net Income forecast?
Projected CAGR
18%

For the last 3 years the compound annual growth rate for Mankind Pharma Ltd's net income is 15%. The projected CAGR for the next 3 years is 18%.

Back to Top